MVT-1075

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameMVT-1075
Drug Alias Name177Lu-DTPA-HuMab-5B177Lu- CHX-A″-DTPAHuMAb- 5B1177Lu Human Monoclonal Antibody 5B1radiolabeled HuMab 5B1 antibody - MabVaxHuMab 5B1 radioimmunotherapy agent - MabVax +[8] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radioactive therapeutic agent +[5] 
Mechanisms of ActionCA19.9(Carbohydrate antigen 19-9) modulators
TargetsCA19.9(Carbohydrate antigen 19-9)
Therapy Area/IndicationsLung NeoplasmsPancreatic NeoplasmsColorectal Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMabvax Therapeutics IncMemorial Sloan Kettering Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesMabvax Therapeutics IncMemorial Sloan Kettering Cancer Center
Inactive CompaniesBiontech Research & Development Inc
Active IndicationsLung NeoplasmsPancreatic NeoplasmsColorectal Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A